We hypothesize that AS alleviates Aβ1-42-induced apoptosis through inhibiting the TLR4/NF-κB signaling pathway in hBMECs, and AS may be potentially developed as a novel agent for the prevention and treatment of patients with AD. Here, NFKB1 is linked to Alzheimer disease.